Filing Details
- Accession Number:
- 0000902664-22-004219
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-09 16:15:34
- Reporting Period:
- 2022-09-07
- Accepted Time:
- 2022-09-09 16:15:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1408443 | Milestone Pharmaceuticals Inc. | MIST | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1493215 | Rtw Investments, Lp | 40 10Th Avenue 7Th Floor New York NY 10014 | No | No | Yes | No | |
1493280 | Roderick Wong | C/O Rtw Investments, Lp 40 10Th Avenue, 7Th Floor New York NY 10014 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares, No Par Value ("Common Shares") | Acquisiton | 2022-09-07 | 1,557,346 | $8.71 | 4,315,102 | No | 4 | P | Indirect | See footnote |
Common Shares | Disposition | 2022-09-07 | 1,557,346 | $8.71 | 4,315,102 | No | 4 | S | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
Footnotes
- Ordinary course rebalancing transactions in which certain RTW Funds (as defined below) rebalance holdings of the Issuer among the RTW Funds. After the transactions reported herein, the amount of Common Shares of the Issuer beneficially owned in the aggregate by the Reporting Persons did not change.
- This Form 4 is being filed by each of (i) RTW Investments, LP (the "Adviser") with respect to Common Shares held by certain investment funds managed by the Adviser (the "RTW Funds"), and (ii) Roderick Wong, M.D., who serves as the Managing Partner and Chief Investment Officer of the Adviser.